159 related articles for article (PubMed ID: 16246257)
21. Subjects with major depression or bipolar disorder show reduction of prodynorphin mRNA expression in discrete nuclei of the amygdaloid complex.
Hurd YL
Mol Psychiatry; 2002; 7(1):75-81. PubMed ID: 11803449
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
Carletti R; Corsi M; Melotto S; Caberlotto L
Eur J Neurosci; 2005 Mar; 21(6):1712-8. PubMed ID: 15845098
[TBL] [Abstract][Full Text] [Related]
23. Expression of Oct-6, a POU III domain transcription factor, in schizophrenia.
Ilia M; Beasley C; Meijer D; Kerwin R; Cotter D; Everall I; Price J
Am J Psychiatry; 2002 Jul; 159(7):1174-82. PubMed ID: 12091196
[TBL] [Abstract][Full Text] [Related]
24. CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.
Kunii Y; Zhang W; Xu Q; Hyde TM; McFadden W; Shin JH; Deep-Soboslay A; Ye T; Li C; Kleinman JE; Wang KH; Lipska BK
Am J Psychiatry; 2015 Nov; 172(11):1122-30. PubMed ID: 26206074
[TBL] [Abstract][Full Text] [Related]
25. Replacement of related POU transcription factors leads to severe defects in mouse forebrain development.
Wolf M; Lommes P; Sock E; Reiprich S; Friedrich RP; Kriesch J; Stolt CC; Bermingham JR; Wegner M
Dev Biol; 2009 Aug; 332(2):418-28. PubMed ID: 19527706
[TBL] [Abstract][Full Text] [Related]
26. Expression of truncated presenilin 2 splice variant in Alzheimer's disease, bipolar disorder, and schizophrenia brain cortex.
Smith MJ; Sharples RA; Evin G; McLean CA; Dean B; Pavey G; Fantino E; Cotton RG; Imaizumi K; Masters CL; Cappai R; Culvenor JG
Brain Res Mol Brain Res; 2004 Aug; 127(1-2):128-35. PubMed ID: 15306129
[TBL] [Abstract][Full Text] [Related]
27. Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.
Barley K; Dracheva S; Byne W
Schizophr Res; 2009 Jul; 112(1-3):54-64. PubMed ID: 19447584
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.
Xing GQ; Russell S; Webster MJ; Post RM
Int J Neuropsychopharmacol; 2004 Jun; 7(2):143-53. PubMed ID: 14741058
[TBL] [Abstract][Full Text] [Related]
29. Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients.
Ding L; Hegde AN
Biol Psychiatry; 2009 Mar; 65(6):541-5. PubMed ID: 19041089
[TBL] [Abstract][Full Text] [Related]
30. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness.
Perlman WR; Webster MJ; Kleinman JE; Weickert CS
Biol Psychiatry; 2004 Dec; 56(11):844-52. PubMed ID: 15576061
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia.
Dean B; Keriakous D; Scarr E; Thomas EA
Aust N Z J Psychiatry; 2007 Apr; 41(4):308-20. PubMed ID: 17464717
[TBL] [Abstract][Full Text] [Related]
32. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
[TBL] [Abstract][Full Text] [Related]
33. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Cwik M; Walkup J; Weis S
Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600
[TBL] [Abstract][Full Text] [Related]
34. Differences in the circuitry-based association of copy numbers and gene expression between the hippocampi of patients with schizophrenia and the hippocampi of patients with bipolar disorder.
Sheng G; Demers M; Subburaju S; Benes FM
Arch Gen Psychiatry; 2012 Jun; 69(6):550-61. PubMed ID: 22309971
[TBL] [Abstract][Full Text] [Related]
35. Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia.
De Luca V; Likhodi O; Van Tol HH; Kennedy JL; Wong AH
Acta Psychiatr Scand; 2006 Sep; 114(3):211-5. PubMed ID: 16889592
[TBL] [Abstract][Full Text] [Related]
36. Malic enzyme 2 and susceptibility to psychosis and mania.
Lee BD; Walss-Bass C; Thompson PM; Dassori A; Montero PA; Medina R; Contreras S; Armas R; Ramirez M; Pereira M; Salazar R; Leach RJ; Quezada P; Raventos H; Escamilla MA
Psychiatry Res; 2007 Feb; 150(1):1-11. PubMed ID: 17258816
[TBL] [Abstract][Full Text] [Related]
37. Oct-6 transcription factor.
Ilia M
Int Rev Neurobiol; 2004; 59():471-89. PubMed ID: 15006499
[TBL] [Abstract][Full Text] [Related]
38. Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study.
Jellinger KA
Acta Neuropathol; 2009 Apr; 117(4):423-7. PubMed ID: 19198857
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of genes encoding neuronal ion-channel subunits in major depression, bipolar disorder and schizophrenia: implications for pathophysiology.
Smolin B; Karry R; Gal-Ben-Ari S; Ben-Shachar D
Int J Neuropsychopharmacol; 2012 Aug; 15(7):869-82. PubMed ID: 22008100
[TBL] [Abstract][Full Text] [Related]
40. Gene and expression analyses reveal enhanced expression of pericentrin 2 (PCNT2) in bipolar disorder.
Anitha A; Nakamura K; Yamada K; Iwayama Y; Toyota T; Takei N; Iwata Y; Suzuki K; Sekine Y; Matsuzaki H; Kawai M; Miyoshi K; Katayama T; Matsuzaki S; Baba K; Honda A; Hattori T; Shimizu S; Kumamoto N; Tohyama M; Yoshikawa T; Mori N
Biol Psychiatry; 2008 Apr; 63(7):678-85. PubMed ID: 17884020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
